US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MetaVia Inc

0.7390

+0.00470.64%

Post-market: 0.74000.0010+0.14%19:59 EDT

Volume:598.93K

Turnover:420.88K

Market Cap:6.40M

PE:-0.21

High:0.7479

Open:0.7000

Low:0.6470

Close:0.7343

Loading ...

Overview Company News Filings

Company Profile

Company Name:

MetaVia Inc

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

9

Office Location:

545 Concord Avenue,Suite 210,Cambridge,Massachusetts,United States

Website:

http://www.neurobopharma.com

Zip Code:

02138

Phone:

Fax:

- -

Introduction:

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity. The company also develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Directors

Name

Position

Andrew Koven

Chairman of the Board

Hyung Heon Kim

Director and Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer

D. Gordon Strickland

Director

Jason L. Groves

Director

Mark A. Glickman

Director

Michael Salsbury

Director

Na Yeon Kim

Director

Shareholders

Name

Position

Hyung Heon Kim

Director and Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MTVA/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","market":"US","secType":"STK","nameCN":"MetaVia Inc","latestPrice":0.739,"timestamp":1744920000000,"preClose":0.7343,"halted":0,"volume":598934,"hourTrading":{"tag":"盘后","latestPrice":0.74,"preClose":0.739,"latestTime":"19:59 EDT","volume":74920,"amount":56411.927041,"timestamp":1744934392880},"delay":0,"floatShares":2336574,"shares":8654869,"eps":-3.56,"marketStatus":"Closed Good Friday","change":0.0047,"latestTime":"04-17 16:00:00 EDT","open":0.7,"high":0.7479,"low":0.647,"amount":420875.6833253,"amplitude":0.13741,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.56,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":0.7343,"preHourTrading":{"tag":"盘前","latestPrice":0.7155,"preClose":0.7323,"latestTime":"09:29 EDT","volume":15573,"amount":11280.1343616,"timestamp":1744896580399},"postHourTrading":{"tag":"盘后","latestPrice":0.74,"preClose":0.739,"latestTime":"19:59 EDT","volume":74920,"amount":56411.927041,"timestamp":1744934392880},"volumeRatio":0.11595326897331375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","floatShares":2336574,"roa":"-92.24%","roe":"-224.18%","lyrEps":-3.556986,"volumeRatio":0.11595326897331375,"shares":8654869,"dividePrice":0,"high":0.7479,"amplitude":0.13741,"preClose":0.7343,"low":0.647,"week52Low":0.647,"pbRate":"0.81","week52High":5.3,"institutionHeld":0,"latestPrice":0.739,"eps":-3.56,"divideRate":0,"volume":598934,"delay":0,"ttmEps":-3.56,"open":0.7,"prevYearClose":2.03,"prevWeekClose":1.45,"prevMonthClose":1.54,"prevQuarterClose":1.54,"fiveDayClose":1.37,"twentyDayClose":1.55,"sixtyDayClose":1.88},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":630763379,"employeeNum":9,"address":"545 Concord Avenue,Suite 210,Cambridge,Massachusetts,United States","zipCode":"02138","officePhone":"857 702 9600"},"stockCompanyDetail":{"websiteUrl":"http://www.neurobopharma.com","stockEarnings":[{"period":"1week","weight":-0.4606},{"period":"1month","weight":-0.5293},{"period":"3month","weight":-0.6201},{"period":"6month","weight":-0.7561},{"period":"1year","weight":-0.7864},{"period":"ytd","weight":-0.636}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity. The company also develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.078486},{"month":2,"riseRate":0.333333,"avgChangeRate":0.050158},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.011768},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.145474},{"month":5,"riseRate":0.25,"avgChangeRate":-0.104755},{"month":6,"riseRate":0.625,"avgChangeRate":0.103229},{"month":7,"riseRate":0.25,"avgChangeRate":-0.022415},{"month":8,"riseRate":0.125,"avgChangeRate":-0.219737},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019058},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.212992},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.100828},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.17607}],"exchange":"NASDAQ","name":"MetaVia Inc","nameEN":"MetaVia Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MTVA\",market:\"US\",,,undefined,":{"directors":[{"name":"Andrew Koven","position":"Chairman of the Board"},{"name":"Hyung Heon Kim","position":"Director and Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer"},{"name":"D. Gordon Strickland","position":"Director"},{"name":"Jason L. Groves","position":"Director"},{"name":"Mark A. Glickman","position":"Director"},{"name":"Michael Salsbury","position":"Director"},{"name":"Na Yeon Kim","position":"Director"}],"executives":[{"name":"Hyung Heon Kim","position":"Director and Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTVA\",params:#limit:5,,,undefined,":[{"date":"2025-03-20","symbol":"MTVA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742457600000,"name":null,"time":"Pre-Market","dateTimestamp":1742443200000,"actualEps":null},{"market":"US","date":"2024-11-07","symbol":"MTVA","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-08-14","symbol":"MTVA","fiscalQuarterEnding":"2024/06","expectedEps":-1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-1.85},{"market":"US","date":"2024-05-09","symbol":"MTVA","fiscalQuarterEnding":"2024/03","expectedEps":-0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-1.32},{"date":"2024-03-28","symbol":"MTVA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711612800000,"name":null,"time":"Pre-Market","dateTimestamp":1711598400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTVA","date":"2025-04-17","current":-0.23033,"percent":1,"low":-0.807761,"twenty":-0.636267,"median":-0.537471,"eighty":-0.476844,"high":-0.23033,"avg":-0.55302,"sd":0.106731,"marketCap":6355270},"quantilePoints":[{"date":"2024-12-06","current":-0.714557,"twenty":-0.800304,"median":-0.792227,"eighty":-0.751814,"marketCap":19816823},{"date":"2024-12-13","current":-0.716111,"twenty":-0.79347,"median":-0.728538,"eighty":-0.7158,"marketCap":19859903},{"date":"2024-12-20","current":-0.546792,"twenty":-0.767348,"median":-0.716111,"eighty":-0.685354,"marketCap":15164177},{"date":"2024-12-27","current":-0.562326,"twenty":-0.746234,"median":-0.70213,"eighty":-0.556112,"marketCap":15594978},{"date":"2025-01-03","current":-0.655529,"twenty":-0.730091,"median":-0.686597,"eighty":-0.553006,"marketCap":18179781},{"date":"2025-01-10","current":-0.661742,"twenty":-0.733198,"median":-0.686597,"eighty":-0.564811,"marketCap":18352101},{"date":"2025-01-17","current":-0.58718,"twenty":-0.720771,"median":-0.663296,"eighty":-0.577238,"marketCap":16284258},{"date":"2025-01-24","current":-0.602714,"twenty":-0.720771,"median":-0.647762,"eighty":-0.584073,"marketCap":16715059},{"date":"2025-01-31","current":-0.584073,"twenty":-0.717664,"median":-0.630675,"eighty":-0.584073,"marketCap":16198098},{"date":"2025-02-07","current":-0.562326,"twenty":-0.716111,"median":-0.615141,"eighty":-0.562326,"marketCap":15594978},{"date":"2025-02-14","current":-0.512617,"twenty":-0.714557,"median":-0.608927,"eighty":-0.546792,"marketCap":14216416},{"date":"2025-02-21","current":-0.509511,"twenty":-0.704615,"median":-0.602714,"eighty":-0.540578,"marketCap":14130256},{"date":"2025-02-28","current":-0.453589,"twenty":-0.699297,"median":-0.58718,"eighty":-0.518583,"marketCap":12579374},{"date":"2025-03-07","current":-0.487763,"twenty":-0.688995,"median":-0.584073,"eighty":-0.503297,"marketCap":13527135},{"date":"2025-03-14","current":-0.467569,"twenty":-0.681626,"median":-0.568539,"eighty":-0.495468,"marketCap":12967095},{"date":"2025-03-21","current":-0.48401,"twenty":-0.667956,"median":-0.562326,"eighty":-0.487763,"marketCap":13354815},{"date":"2025-03-28","current":-0.48933,"twenty":-0.662363,"median":-0.546792,"eighty":-0.487763,"marketCap":13501595},{"date":"2025-04-04","current":-0.47992,"twenty":-0.656772,"median":-0.540578,"eighty":-0.485083,"marketCap":13241949},{"date":"2025-04-11","current":-0.429732,"twenty":-0.643102,"median":-0.539025,"eighty":-0.482756,"marketCap":11857170},{"date":"2025-04-17","current":-0.23033,"twenty":-0.636267,"median":-0.537471,"eighty":-0.476844,"marketCap":6355270}],"updateTime":1745002800269}}}